BAJFINANCE vs DRREDDY: Stock Comparison
BAJAJ FINANCE is the larger company by market capitalisation. BAJAJ FINANCE shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BAJFINANCE leads 8; DRREDDY leads 3 of 12
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| Sector | Financial Services | Healthcare |
| Industry | Non Banking Financial Company (NBFC) | Pharmaceuticals |
Price
| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| Live Price | ₹928.95 | ₹1,229.5 |
| Day Change | -1.4% | -0.77% |
| Volume | 62.71 L | 15.5 L |
| 52-Week High | ₹1,176.4 | ₹1,414.9 |
| 52-Week Low | ₹787.9 | ₹1,101 |
| Distance from 52W High | -21.03% | -13.1% |
Valuation
| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| Market Cap | ₹5.77 L Cr | ₹1.02 L Cr |
| P/E Ratio | 26.6x | 31.71x |
| P/B Ratio | 4.68x | 2.7x |
| EPS | ₹9.61 | ₹5.32 |
| Book Value | ₹187.9 | ₹458.03 |
| Dividend Yield | 0.65% | 0.65% |
Growth
| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| Revenue Growth (TTM YoY) | 26.8% | -11.6% |
| EPS Growth (TTM YoY) | 21.4% | -86.2% |
| Qtr Sales Growth | 0% | 7.33% |
| Qtr Profit Growth | 0% | 96.84% |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| ROE | 17.26% | 10.27% |
| ROCE | 15.33% | 12.07% |
| Net Margin | 37.88% | 12.76% |
| Operating Margin | 64.07% | 21.43% |
| Debt to Equity | 1.14x | 0.17x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | BAJFINANCE | DRREDDY |
|---|---|---|
| Promoter Holding | 54.67% | 26.64%▲ 0.01 pp |
| FII Holding | 19.79%▼ 0.42 pp | 32.07%▼ 1.01 pp |
| DII Holding | 17.05%▲ 0.65 pp | 31.74%▲ 1.02 pp |
| Public Holding | 8.46%▼ 0.18 pp | 9.35%▲ 0.02 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BAJAJ FINANCE and DR. REDDY S LABORATORIES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.